NAD+ Deep Dive: The Coenzyme Behind Longevity Research

NAD+ shows up constantly alongside peptides in longevity and wellness research contexts, so it earns a place in this series — with one important clarification up front.

What It Is (and What It Isn't)

NAD+ (nicotinamide adenine dinucleotide) is not a peptide. It's a coenzyme — a small molecule that helps enzymes carry out chemical reactions — found in every living cell, where it plays a central role in converting food into cellular energy. It's grouped alongside peptides in research and wellness marketing because it's sold and studied in similar contexts (injectable/IV research formats, longevity science), but structurally and biologically it's a distinct category of molecule.

Why It's Studied

NAD+ is essential to mitochondrial energy production and also serves as a required "fuel" for sirtuins — a family of proteins heavily studied in aging research for their role in cellular repair and stress resistance. NAD+ levels are well documented to decline with age, which is the central premise behind the surge of research and commercial interest in NAD+ and its precursor molecules (such as NMN and NR, which the body converts into NAD+).

What Research Has Explored

• Cellular energy metabolism — the foundational, well-established area of NAD+ biochemistry.
• Sirtuin activation and aging biology — a major, active area of aging research connecting NAD+ availability to cellular repair mechanisms.
• Age-related NAD+ decline — well-documented in the literature, forming the basis for interest in supplementation or direct administration.
• Neurodegeneration and metabolic disease — earlier-stage research exploring NAD+'s relationship to conditions where cellular energy dysfunction plays a role.

Evidence Quality

The foundational biochemistry of NAD+'s role in metabolism is extremely well established — this is textbook cell biology, not a fringe hypothesis. Where the evidence gets thinner is in translating that foundational science into specific outcome claims for direct NAD+ administration in humans (via IV or injection, as opposed to precursor supplementation, which has its own separate and still-developing human trial base). Much of the excitement in this space currently outpaces the number of large, controlled human trials specifically measuring outcomes from direct NAD+ administration.

Safety & Research Considerations

Because NAD+ is chemically distinct from peptides, it has its own stability, formulation, and storage considerations. As with any research compound, purity verification and clear labeling from your supplier matter — see our supplier checklist for what to look for regardless of category.

Bottom Line

NAD+'s foundational role in cellular energy and aging biology is scientifically well-established, even though it isn't technically a peptide — but specific outcome claims for direct administration are still an active, developing area of research rather than settled science.